DCM
OFIX icon

Dupont Capital Management’s Orthofix Medical OFIX Stock Holding History

Dupont Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,611
Closed -$287K – 1799
2021
Q1 		$287K Sell
6,611
-1,356
-17% -$59.8K 0.01% 1163
2020
Q4 		$342K Sell
7,967
-595
-7% -$21.7K 0.01% 994
2020
Q3 		$267K Sell
8,562
-574
-6% -$17.8K 0.01% 1016
2020
Q2 		$292K Sell
9,136
-5,278
-37% -$175K 0.01% 977
2020
Q1 		$404K Sell
14,414
-10,975
-43% -$425K 0.01% 750
2019
Q4 		$1.17M Hold
25,389
– – 0.03% 523
2019
Q3 		$1.35M Buy
25,389
+12,452
+96% +$642K 0.03% 442
2019
Q2 		$684K Buy
+12,937
New +$688K 0.02% 656
2016
Q3 		– Sell
-31,262
Closed -$1.33M – 693
2016
Q2 		$1.33M Buy
31,262
+19,252
+160% +$837K 0.03% 381
2016
Q1 		$499K Buy
+12,010
New +$471K 0.01% 546

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Dupont Capital Management's OFIX Position: Q2 2021 in Review

Dupont Capital Management sold out of Orthofix Medical (OFIX) in Q2 2021, closing a stake of 6,611 shares — an estimated $287K sold.

Dupont Capital Management first reported a position in OFIX in Q1 2016 and held it in 10 quarters. The position peaked at $1.35M in Q3 2019. 134 funds tracked by Wall St. Rank hold OFIX as of Q2 2021.

  • Dupont Capital Management reported no remaining Orthofix Medical position as of Q2 2021 after selling out during the quarter.
  • Dupont Capital Management sold 6,611 Orthofix Medical shares in Q2 2021, an estimated $287K.
  • Dupont Capital Management first reported a position in Orthofix Medical in Q1 2016 and held it in 10 quarters.
  • Dupont Capital Management's Orthofix Medical position peaked at $1.35M in Q3 2019.
  • 134 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2021.

Based on Dupont Capital Management's 13F filing for Q2 2021, filed 30 Jul 2021.